Thomas Civik
CEO & Chairman of the Board, Director · Pyxis Oncology, Inc.
Individual
- 2026
- Sep 8, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas Civik files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jakob Dupont - $107K in PYXS purchases and sales in the last 12 months
- GordonMD Global Investments LP - PYXS
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas Civik?
Thomas Civik is a corporate insider, tracked as CEO & Chairman of the Board, Director of Pyxis Oncology, Inc. (PYXS). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Thomas Civik submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
